Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.4 USD | -4.47% | -6.48% | -42.69% |
Apr. 25 | Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained | MT |
Apr. 25 | Transcript : Sage Therapeutics, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.69% | 781M | |
+4.05% | 106B | |
+7.02% | 23.47B | |
-14.65% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-10.11% | 16.78B | |
+5.42% | 14.41B | |
+35.25% | 12.86B | |
+325.09% | 8.78B |
- Stock Market
- Equities
- SAGE Stock
- News Sage Therapeutics, Inc.
- Sage Therapeutics to Lay Off 40% Staff Amid Efforts to Support Financial Position